Eradication of hepatitis C virus with direct‐acting antivirals improves glycemic control in diabetes: A multicenter study

Eradication of hepatitis C virus with direct‐acting antivirals improves glycemic control in diabetes: A multicenter study

Abstract Background and Aim Hepatitis C virus (HCV) infection causes insulin resistance and diabetes as extrahepatic manifestations. We aimed to analyze the effect of HCV eradication by direct‐acting antiviral (DAA) agents on glucose tolerance. Methods The hemoglobin A1c (HbA1c) of 272 patients with...

Full description

Bibliographic Details
Main Authors: Hirokazu Takahashi, Takashi Nakahara, Tomomi Kogiso, Kento Imajo, Takaomi Kessoku, Takumi Kawaguchi, Tatsuya Ide, Miwa Kawanaka, Hideyuki Hyogo, Hideki Fujii, Masafumi Ono, Yoshihiro Kamada, Yoshio Sumida, Keizo Anzai, Masahito Shimizu, Takuji Torimura, Atsushi Nakajima, Katsutoshi Tokushige, Kazuaki Chayama, Yuichiro Eguchi, Japan Study Group of NAFLD (JSG‐NAFLD)
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:JGH Open
Subjects:
direct‐acting antivirals
fasting plasma glucose
hemoglobin A1c
hepatitis C virus
Online Access:https://doi.org/10.1002/jgh3.12474

Internet

https://doi.org/10.1002/jgh3.12474

Similar Items